Stephen Daniells (William Reed Business Media Ltd.) discusses what emerged at Probiota Global 2022.
Can a mutual solution be found for probiotics in Europe? Legal analysis, dilemmas, solutions are the topics of the webinar by IPA Europe, 4 April 2022.
A recent study investigates the role of the gut microbiota in helping the gallbladder regulate the innate immune response
The findings could help to develop microbiota-based strategies to advance immunothery treatments for melanoma.
New research reveals that ocean-derived genes are common in the human microbiota, highlighting the interplay between diet and adaptation of human gut microbes.
Researchers have found that β-carotene modifies the abundance of certain gut microbes and improves the intestinal dysfunctions
Researchers have found that combining a probiotic product with immunotherapy may boost anti-tumor responses in people with advanced kidney cancer.
Researchers have found that Lactobacilli could be used to treat common acne lesions, reducing the need for topical antibiotics.
Researchers have found that some gut microbes may be connected to depression, thus highlighting that the intricate relationship between humans and their microbiota could have important health implications.
The International Probiotics Association and the European Dairy Association are jointly asking to reinforce their involvement in the definition of the current view of probiotic products in Europe
